AstraZeneca rebuffs Pfizer approach, report claims
This article was originally published in Scrip
US big pharma company Pfizer has approached its UK rival AstraZeneca with a £60bn takeover offer, reports The Sunday Times (20 April). AstraZeneca allegedly rebuffed the advance and talks have been discontinued. If such an offer was indeed made, it would equate to roughly £48 per AstraZeneca share, a premium of more than 25% above its last close.